greenhouse clinic LLC

NYS Entity Status
INACTIVE

NYS Filing Date
JULY 14, 2014

NYS DOS ID#
4605913

County

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY RESERVATION

Name History
2014 - GREENHOUSE CLINIC LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • The Top 10 Moments of New York Fashion Week
    By THE NEW YORK TIMES - Friday Sep 15, 2017

    Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.

    Source: NYT > Home Page
  • Trump’s Tough Talk on North Korea Puts Japan’s Leader in Delicate Spot
    By JONATHAN SOBLE - Friday Aug 11, 2017

    North Korea’s accelerating military advances — and President Trump’s volatile response — could complicate Japan’s close alliance with the United States.

    Source: NYT > Home Page
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
  • Europa’s future: A runaway greenhouse
    By John Timmer - Tuesday Aug 1, 2017

    A detailed climate model suggests that, as stars brighten, planets get hot fast.

    Source: Ars Technica
  • Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing
    By Ben Fidler - Monday Sep 11, 2017

    A new drug for patients who have a hard time controlling their asthma could be nearing an FDA review. Tarrytown, NY-based Regeneron Pharmaceuticals (NASDAQ: REGN) and partner Sanofi this morning are touting results this morning from a 1,902-patient Phase 3 study called Liberty Asthma Quest. In it, their injectable antibody drug dupilumab (Dupixent), already approved […]

    Source: Xconomy New York
greenhouse clinic llc ny